David Broecker

David Broecker, Legacy BioSciences Consulting Founder

David is an experienced life sciences executive with a passion and track record for building organizations and creating value by advancing breakthrough innovation to the marketplace. He is the founding President and CEO of the Indiana Biosciences Research Institute in Indianapolis, IN – an independent, non-profit research organization dedicated to discovery science and applied research initially targeting diabetes, cardio-metabolic disease, and poor nutrition, inspired by the state’s leading life sciences companies. David was President and CEO of Alkermes, a publicly traded biotechnology company, leading the organization through significant transformation with the launch of several new products, including Vivitrol – the only long acting treatment for alcohol and opiate dependence. As both an intra- and entrepreneur, he has led teams in a range of organizations, including multiple start-ups. David started his career at Eli Lilly and Company and over 15 years was responsible for supporting the development and commercialization of multiple pharmaceutical, medical device, and diagnostic products.

He currently serves on the boards of Zorion Medical, Inc., and Apexian Pharmaceuticals. He is on the advisory boards for AIT BioSciences and Embera. David is a trustee at Wabash College and member of Purdue Research Foundation board.